Latest Articles
Women face $1200 bill as key endo drug axed from PBS - The Cairns Post
Women face $1200 bill as key endo drug axed from PBS The Cairns Post
Published: May 19, 2026, 7:47 p.m.
Why More Working Women In Their 30s Are Being Diagnosed With Endometriosis - BW Healthcare World
Why More Working Women In Their 30s Are Being Diagnosed With Endometriosis BW Healthcare World
Published: May 19, 2026, 7:18 p.m.
Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial - TipRanks
Pfizer Takes Aim at Merck in New Phase 3 Endometrial Cancer Trial TipRanks
Published: May 19, 2026, 4:44 p.m.
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study - Yahoo Finance
Merck's ADC Candidate Meets Goals in Endometrial Cancer Study Yahoo Finance
Published: May 19, 2026, 3:47 p.m.
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease - Pharmacy Times
GLP-1s May Help Reduce Endometrial Cancer Risk in Patients With Obesity and Metabolic Disease Pharmacy Times
Published: May 19, 2026, 3:15 p.m.
Easing pain: Way to slash endometriosis diagnosis by years - Gold Coast Bulletin
Easing pain: Way to slash endometriosis diagnosis by years Gold Coast Bulletin
Published: May 19, 2026, 2:33 p.m.
Thank You For Signing Up | EndoFound SMS Updates - Endometriosis Foundation of America
Thank You For Signing Up | EndoFound SMS Updates Endometriosis Foundation of America
Published: May 19, 2026, 2:13 p.m.
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer - TradingView
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer TradingView
Published: May 19, 2026, 2 p.m.
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis - News-Medical
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis News-Medical
Published: May 19, 2026, 12:42 p.m.
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer - BioSpace
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer BioSpace
Published: May 19, 2026, 11:19 a.m.
Link copied to clipboard!